
Opinion|Videos|February 21, 2025
Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies
Panelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- As treatments with greater durability emerge, how might they change your approach to treating neovascular age-related macular degeneration or diabetic macular edema? What impact will this have on treatment and monitoring schedules?
- How will this impact workflows and clinic capacity?
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Current and Emerging Treatments for Geographic Atrophy and When to Initiate Therapy
2
AAO 2025: Subretinal drusenoid deposits in Black and Hispanic patients with AMD
3
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
4